Our community narratives are driven by numbers and valuation.
Dear Inotiv, My name is Jong Ik Kwon, DVM , a graduate of Seoul National University College of Veterinary Medicine. Earlier in my career, I worked for Kwangdong Pharmaceutical as a Clinical Research Manager (CRM) for two years , where I gained direct experience in clinical development, regulatory processes, and pharmaceutical operations.Read more

I think everyone who is invested in the American stock market has their eyes on Netflix as of late. Especially after the company declined to raise their offer for Warner Brothers in their bidding war against Paramount Skydance.Read more
1) Catalysts — What Could Meaningfully Move Sales or Earnings? Regulatory & Commercial Milestones ✔ TGA Approval for Felix in Australia Memphasys recently received approval from the Therapeutic Goods Administration (TGA) in Australia for its Felix™ sperm separation system , enabling immediate commercial sales and deployment here — ahead of schedule.Read more
Alphabet Inc. (GOOG) is currently operating at the epicenter of the global generative AI revolution, with its stock trading at $303.45 as of the March 4, 2026, market close.Read more
NEXTDC Limited is a leading Australian digital infrastructure provider that develops and operates high-performance data centres across major cities. The company supports enterprise clients, government agencies and hyperscale cloud providers through colocation services, interconnection networks and direct cloud on-ramps to platforms such as AWS, Microsoft Azure and Google Cloud.Read more
Lynas Rare Earths (ASX: LYC): A Leveraged Bet on Rare Earth Prices and Supply Chain Diversification Key Takeaways Lynas Rare Earths is the largest producer of separated rare earths outside China , making it strategically important in the global push to diversify critical mineral supply chains. Neodymium-Praseodymium (NdPr) oxide drives the majority of Lynas’ revenue , and earnings are highly sensitive to its price.Read more
Okay, so you are probably thinking… yeah right, here’s that degenerate Double Bubbler banging on about that penny stock again. Well take a brief moment and read the following to see why my opinion is not so outlandish.Read more

Meta Platforms is currently commanding the spotlight as a leader in the generative AI arms race, with its stock trading at $667.73 as of the March 4, 2026, market close. The shares rose 1.93% today, outperforming the broader tech sector as investors react positively to news of expanded AI compute deals with AMD and Google.Read more
1. Momentum & Trend Indicators The MACD is positive at 0.42, suggesting bullish momentum, yet the share price (A$122.35) is just above the 20-day EMA(121.06) and below the 50-day SMA(120.80) – a tug-of-war that keeps the overall trend “neutral-to-bullish”.Read more





